title: The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
abstract: The plasminogen activator (PA) system has been proposed to have important roles in rheumatoid arthritis. Here we have used the autoimmune collagen type II (CII)-induced arthritis (CIA) model and mice deficient for urokinase-type PA (uPA) or plasminogen to investigate the role of the PA system for development of arthritis. Our data revealed that uPA-deficient mice have a lower severity and incidence of CIA than wild-type mice. Furthermore, although >80% of wild-type control mice developed CIA, we found that none of the 50 plasminogen-deficient littermates that were tested developed CIA within a 40-day period. Antibody generation after CII immunization as well as the binding of labeled anti-CII antibodies to the surface of cartilage were similar in wild-type and plasminogen-deficient mice. No sign of inflammation was seen when plasminogen-deficient mice were injected with a mixture of monoclonal antibodies against CII. However, after daily injections of human plasminogen, these mice developed arthritis within 5 days. Our finding that infiltration of inflammatory cells into the synovial joints was impaired in plasminogen-deficient mice suggests that uPA and plasminogen are important mediators of joint inflammation. Active plasmin is therefore essential for the induction of pathological inflammatory joint destruction in CIA.
authors.affiliation: Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.
authors.forename: Jinan
authors.initials: J
authors.lastname: Li
authors.forename: Annelii
authors.initials: A
authors.lastname: Ny
authors.forename: Göran
authors.initials: G
authors.lastname: Leonardsson
authors.forename: Kutty Selva
authors.initials: KS
authors.lastname: Nandakumar
authors.forename: Rikard
authors.initials: R
authors.lastname: Holmdahl
authors.forename: Tor
authors.initials: T
authors.lastname: Ny
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D001168:Arthritis / Q000276:immunology* / Q000473:pathology; D001169:Arthritis, Experimental / Q000276:immunology* / Q000473:pathology; D024043:Collagen Type II / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes; D005341:Fibrinolysin / Q000378:metabolism*; D007150:Immunohistochemistry; D007249:Inflammation / Q000378:metabolism*; D007596:Joints / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D010958:Plasminogen / Q000378:metabolism* / Q000502:physiology*; D010960:Plasminogen Activators / Q000378:metabolism*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D024043:Collagen Type II; D000939:Epitopes; D010958:Plasminogen; D010960:Plasminogen Activators; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator
references.citation: Eur J Immunol. 2001 Jun;31(6):1847-56
references.pmid: 11433381
references.citation: Clin Exp Rheumatol. 1999 Jul-Aug;17(4):485-98
references.pmid: 10464565
references.citation: Ageing Res Rev. 2002 Feb;1(1):135-47
references.pmid: 12039453
references.citation: J Immunol. 2002 Jul 1;169(1):454-9
references.pmid: 12077276
references.citation: Arthritis Rheum. 2002 Sep;46(9):2339-48
references.pmid: 12355481
references.citation: Eur J Immunol. 2002 Oct;32(10):2915-22
references.pmid: 12355445
references.citation: J Exp Med. 2002 Dec 2;196(11):1461-71
references.pmid: 12461081
references.citation: Eur J Immunol. 2003 Aug;33(8):2269-77
references.pmid: 12884302
references.citation: Am J Pathol. 2003 Nov;163(5):1827-37
references.pmid: 14578183
references.citation: Eur J Immunol. 2004 Apr;34(4):1208-16
references.pmid: 15048732
references.citation: J Exp Med. 1967 Aug 1;126(2):189-206
references.pmid: 4226271
references.citation: N Engl J Med. 1977 May 5;296(18):1017-23
references.pmid: 66627
references.citation: J Exp Med. 1977 Sep 1;146(3):857-68
references.pmid: 894190
references.citation: Lab Invest. 1982 Mar;46(3):321-43
references.pmid: 7062727
references.citation: Arthritis Rheum. 1986 Mar;29(3):400-10
references.pmid: 2421741
references.citation: Immunogenetics. 1986;24(2):84-9
references.pmid: 3744440
references.citation: Arthritis Rheum. 1986 Nov;29(11):1397-401
references.pmid: 3096341
references.citation: Arthritis Rheum. 1987 Apr;30(4):460-5
references.pmid: 3580014
references.citation: Lab Invest. 1988 Jan;58(1):53-60
references.pmid: 3257283
references.citation: Annu Rev Cell Biol. 1988;4:93-126
references.pmid: 3143380
references.citation: J Lab Clin Med. 1989 Jan;113(1):94-102
references.pmid: 2521240
references.citation: Int Rev Immunol. 1988 Sep;4(1):49-64
references.pmid: 3072385
references.citation: Proc Natl Acad Sci U S A. 1989 Dec;86(23):9475-9
references.pmid: 2512582
references.citation: Scand J Immunol. 1990 Feb;31(2):147-57
references.pmid: 1968678
references.citation: Eur J Immunol. 1990 May;20(5):1061-6
references.pmid: 1694131
references.citation: Immunol Rev. 1990 Dec;118:193-232
references.pmid: 2079326
references.citation: Autoimmunity. 1991;10(1):27-34
references.pmid: 1720677
references.citation: Arthritis Rheum. 1992 Aug;35(8):884-93
references.pmid: 1379429
references.citation: J Rheumatol. 1993 Jan;20(1):91-6
references.pmid: 8441174
references.citation: J Cell Biol. 1993 Aug;122(3):673-84
references.pmid: 8393013
references.citation: Am J Pathol. 2002 Mar;160(3):917-26
references.pmid: 11891190
references.citation: Endocrinology. 1999 Nov;140(11):5030-5
references.pmid: 10537128
references.citation: Thromb Res. 1993 Jul 1;71(1):1-45
references.pmid: 7690164
references.citation: Nature. 1994 Mar 31;368(6470):419-24
references.pmid: 8133887
references.citation: Thromb Haemost. 1999 Aug;82(2):259-70
references.pmid: 10605712
references.citation: J Immunol. 2000 Apr 15;164(8):4340-7
references.pmid: 10754334
references.citation: Methods. 2000 Jun;21(2):103-10
references.pmid: 10816371
references.citation: Arthritis Rheum. 2000 Aug;43(8):1710-8
references.pmid: 10943860
references.citation: Rheumatology (Oxford). 2001 Feb;40(2):205-11
references.pmid: 11257159
references.citation: Eur J Immunol. 1994 Jul;24(7):1698-702
references.pmid: 8026530
references.citation: J Biol Chem. 1995 Jul 14;270(28):16886-94
references.pmid: 7622505
references.citation: Circulation. 1995 Nov 1;92(9):2585-93
references.pmid: 7586361
references.citation: Nat Med. 1996 Mar;2(3):287-92
references.pmid: 8612226
references.citation: Cell. 1996 May 3;85(3):307-10
references.pmid: 8616886
references.citation: Ann Rheum Dis. 1996 Apr;55(4):230-6
references.pmid: 8733439
references.citation: Blood. 1996 Aug 1;88(3):870-6
references.pmid: 8704243
references.citation: Autoimmunity. 1995;22(3):137-47
references.pmid: 8734568
references.citation: J Immunol. 1996 Sep 15;157(6):2440-8
references.pmid: 8805643
references.citation: Eur J Biochem. 1997 Mar 1;244(2):487-93
references.pmid: 9119016
references.citation: Coron Artery Dis. 1997 Jan;8(1):9-18
references.pmid: 9101117
references.citation: Int J Cancer. 1997 Jul 3;72(1):1-22
references.pmid: 9212216
references.citation: Life Sci. 1997;61(19):1861-78
references.pmid: 9364191
references.citation: J Biol Chem. 1998 Jan 16;273(3):1551-61
references.pmid: 9430695
references.citation: Blood. 1998 Mar 15;91(6):2005-9
references.pmid: 9490683
references.citation: Arch Immunol Ther Exp (Warsz). 1998;46(1):1-7
references.pmid: 9510939
references.citation: Mol Med Today. 1998 Mar;4(3):130-7
references.pmid: 9575496
references.citation: J Clin Invest. 1998 Jul 1;102(1):41-50
references.pmid: 9649555
references.citation: J Clin Invest. 1999 Jan;103(1):81-7
references.pmid: 9884337
references.citation: Ann Rheum Dis. 1999 Jul;58(7):446-50
references.pmid: 10381490
references.citation: Int Immunol. 1999 Jul;11(7):1065-73
references.pmid: 10383939